Up-regulation of RPL6 accelerated cell growth and enhanced in vitro colony formation of gastric cancer cells, while down-regulation of RPL6 could suppress cell cycle progression, at least partially through down-regulating cyclin E, indicating that RPL6 might be used as a novel therapeutic target for gastric cancer [4]. The gene discussed is CCNE1; the disease is gastric cancer.